Showing results 1 to 20 of 28
next >
| Issue Date | Title | Author(s) |
| 2023-09-22 | A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models. | Cortesi, M; Liu, D; Yee, C; Marsh, DJ; Ford, CE |
| 2021-08 | Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling. | Bolitho, C; Moscova, M; Baxter, RC; Marsh, DJ |
| 2021-10-22 | An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles. | Joshi, N; Liu, D; Dickson, K-A; Marsh, DJ; Ford, CE; Stenzel, MH |
| 2016-05-18 | Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing | Cole, AJ; Dwight, T; Gill, AJ; Dickson, KA; Zhu, Y; Clarkson, A; Gard, GB; Maidens, J; Valmadre, S; Clifton-Bligh, R; Marsh, DJ |
| 2024-01-09 | Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models. | Cortesi, M; Liu, D; Yee, C; Marsh, DJ; Ford, CE |
| 2018-01-01 | Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer | Shah, JS; Gard, GB; Yang, J; Maidens, J; Valmadre, S; Soon, PS; Marsh, DJ |
| 2016-04-01 | Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs | Shah, JS; Soon, PS; Marsh, DJ |
| 2017-09-05 | Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency | Cole, AJ; Zhu, Y; Dwight, T; Yu, B; Dickson, KA; Gard, GB; Maidens, J; Valmadre, S; Gill, AJ; Clifton-Bligh, R; Marsh, DJ |
| 2023-08-26 | CRISPR single base-editing: in silico predictions to variant clonal cell lines. | Dickson, K-A; Field, N; Blackman, T; Ma, Y; Xie, T; Kurangil, E; Idrees, S; Rathnayake, SNH; Mahbub, RM; Faiz, A; Marsh, DJ |
| 2012-12-28 | Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer | Kan, CWS; Hahn, MA; Gard, GB; Maidens, J; Huh, JY; Marsh, DJ; Howell, VM |
| 2005-07-01 | A HIf1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas | Dahia, PLM; Ross, KN; Wright, ME; Hayashida, CY; Santagata, S; Barontini, M; Kung, AL; Sanso, G; Powers, JF; Tischler, AS; Hodin, R; Heitritter, S; Moore, F; Dluhy, R; Sosa, JA; Ocal, IT; Benn, DE; Marsh, DJ; Robinson, BG; Schneider, K; Garber, J; Arum, SM; Korbonits, M; Grossman, A; Pigny, P; Toledo, SPA; Nose, V; Li, C; Stiles, CD |
| 2014-01-01 | Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets | Marsh, DJ; Shah, JS; Cole, AJ |
| 2016-12 | Host-Guest Complexes of Carboxylated Pillar[n]arenes With Drugs. | Wheate, NJ; Dickson, K-A; Kim, RR; Nematollahi, A; Macquart, RB; Kayser, V; Yu, G; Church, WB; Marsh, DJ |
| 1999-01-01 | Mutation and deletion analysis of GFRα-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours | Gimm, O; Gössling, A; Marsh, DJ; Dahia, PLM; Mulligan, LM; Von Deimling, A; Eng, C |
| 2014-06-16 | Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer | Chung, L; Moore, K; Phillips, L; Boyle, FM; Marsh, DJ; Baxter, RC |
| 2023-02-18 | Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. | Pitiyarachchi, O; Lee, YC; Sim, H-W; Srirangan, S; Mapagu, C; Kirk, J; Harnett, PR; Balleine, RL; Bowtell, DDL; Samimi, G; Brand, AH; Marsh, DJ; Beale, P; Anderson, L; Bouantoun, N; Provan, P; INOVATe Investigators,; Ramus, SJ; DeFazio, A; Friedlander, M |
| 2019-01-01 | Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) parathyroid tumors demonstrate distinctive morphologic features | Gill, AJ; Lim, G; Cheung, VKY; Andrici, J; Perry-Keene, JL; Paik, J; Sioson, L; Clarkson, A; Sheen, A; Luxford, C; Elston, MS; Meyer-Rochow, GY; Nano, MT; Kruijff, S; Engelsman, AF; Sywak, M; Sidhu, SB; Delbridge, LW; Robinson, BG; Marsh, DJ; Toon, CW; Chou, A; Clifton-Bligh, RJ |
| - | PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer | Dickson, K-A; Xie, T; Evenhuis, C; Ma, Y; Marsh, DJ |
| 2023-10-12 | PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Travis, G; McGowan, EM; Simpson, AM; Marsh, DJ; Nassif, NT |
| 2021-01 | Studying the Oncosuppressive Functions of PTENP1 as a ceRNA. | Travis, G; Haddadi, N; Simpson, AM; Marsh, DJ; McGowan, EM; Nassif, NT |
